CROSS COUNTRY HEALTHCARE INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CROSS COUNTRY HEALTHCARE INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $200.91M | Mar 1, 2019 |
| FY2018 | Sep 30, 2018 | $200.72M | Mar 1, 2019 |
| FY2018 | Jun 30, 2018 | $204.57M | Mar 1, 2019 |
| FY2018 | Mar 31, 2018 | $210.29M | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | $219.67M | Mar 1, 2019 |
| FY2018 | Sep 30, 2017 | $228.49M | Mar 1, 2019 |
| FY2018 | Jun 30, 2017 | $209.31M | Mar 1, 2019 |
| FY2018 | Mar 31, 2017 | $207.57M | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $833.54M | Mar 1, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $236.76M | Mar 9, 2026 |
| FY2025 | Sep 30, 2025 | $250.05M | Mar 9, 2026 |
| FY2025 | Jun 30, 2025 | $274.07M | Mar 9, 2026 |
| FY2025 | Mar 31, 2025 | $293.41M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $309.94M | Mar 9, 2026 |
| FY2025 | Sep 30, 2024 | $315.12M | Mar 9, 2026 |
| FY2025 | Jun 30, 2024 | $339.77M | Mar 9, 2026 |
| FY2025 | Mar 31, 2024 | $379.17M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $414.04M | Mar 5, 2025 |
| FY2024 | Sep 30, 2023 | $442.29M | Mar 5, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.98M | Mar 9, 2026 |
| FY2025 | Sep 30, 2025 | $50.93M | Mar 9, 2026 |
| FY2025 | Jun 30, 2025 | $56.00M | Mar 9, 2026 |
| FY2025 | Mar 31, 2025 | $58.66M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $61.99M | Mar 9, 2026 |
| FY2025 | Sep 30, 2024 | $64.16M | Mar 9, 2026 |
| FY2025 | Jun 30, 2024 | $70.81M | Mar 9, 2026 |
| FY2025 | Mar 31, 2024 | $77.30M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $90.49M | Mar 5, 2025 |
| FY2024 | Sep 30, 2023 | $97.36M | Mar 5, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($82.93M) | Mar 9, 2026 |
| FY2025 | Sep 30, 2025 | ($4.77M) | Mar 9, 2026 |
| FY2025 | Jun 30, 2025 | ($6.66M) | Mar 9, 2026 |
| FY2025 | Mar 31, 2025 | ($490.0K) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($3.75M) | Mar 9, 2026 |
| FY2025 | Sep 30, 2024 | $2.56M | Mar 9, 2026 |
| FY2025 | Jun 30, 2024 | ($16.05M) | Mar 9, 2026 |
| FY2025 | Mar 31, 2024 | $2.69M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $9.04M | Mar 5, 2025 |
| FY2024 | Sep 30, 2023 | $12.81M | Mar 5, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($84.41M) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($16.87M) | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $112.71M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $269.88M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $139.30M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | ($9.16M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | ($15.71M) | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | ($12.88M) | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $11.75M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $6.18M | Mar 1, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $200.68M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $233.38M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $300.33M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $324.21M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $216.36M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $173.81M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $181.96M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $180.23M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $187.44M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $179.82M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.25M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $120.12M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $248.50M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $134.05M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | ($85.62M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $27.20M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $5.54M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $21.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $45.51M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $30.15M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.16M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $8.71M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $13.97M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $8.79M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $7.17M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $4.62M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $2.94M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $4.60M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $5.11M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $6.52M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $448.95M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $589.25M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $681.06M | Mar 5, 2025 |
| FY2024 | Dec 31, 2022 | $949.59M | Mar 5, 2025 |
| FY2022 | Dec 31, 2021 | $732.81M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $356.97M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $382.37M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $427.00M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $467.69M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $388.38M | Mar 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $126.13M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $170.29M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $213.41M | Mar 5, 2025 |
| FY2024 | Dec 31, 2022 | $498.11M | Mar 5, 2025 |
| FY2022 | Dec 31, 2021 | $435.28M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $202.06M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $218.87M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $208.81M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $229.97M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $236.58M | Mar 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $322.82M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $418.96M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $467.65M | Mar 9, 2026 |
| FY2025 | Dec 31, 2022 | $451.48M | Mar 9, 2026 |
| FY2024 | Dec 31, 2021 | $294.27M | Mar 5, 2025 |
| FY2021 | Dec 31, 2020 | $154.38M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $162.63M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $217.53M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $237.09M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $151.24M | Mar 2, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.80M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $135.06M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $135.43M | Mar 5, 2025 |
| FY2024 | Dec 31, 2022 | $163.27M | Mar 5, 2025 |
| FY2022 | Dec 31, 2021 | $119.49M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $90.92M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $101.07M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $101.06M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $117.59M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $79.65M | Mar 2, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.21M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $218.06M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $232.62M | Mar 5, 2025 |
| FY2024 | Dec 31, 2022 | $159.98M | Mar 5, 2025 |
| FY2022 | Dec 31, 2021 | ($22.74M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($154.74M) | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | ($141.78M) | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | ($84.06M) | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | ($67.11M) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($104.09M) | Mar 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $108.74M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $81.63M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $17.09M | Mar 5, 2025 |
| FY2024 | Dec 31, 2022 | $3.60M | Mar 5, 2025 |
| FY2022 | Dec 31, 2021 | $1.04M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.60M | Feb 28, 2022 |
| FY2018 | Dec 31, 2018 | $16.02M | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | $25.54M | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $20.63M | Mar 1, 2019 |
| FY2018 | Dec 31, 2015 | $2.45M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $70.97M | Mar 5, 2020 |
| FY2019 | Dec 31, 2018 | $83.18M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $93.13M | Mar 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 9, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 5, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 5, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 9, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 5, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 5, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31.72M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 32.28M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | 34.38M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | 36.30M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 37.02M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 36.18M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 35.87M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 35.63M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | 35.84M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 32.34M | Mar 2, 2018 |